ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
AbCellera Biologics Inc

AbCellera Biologics Inc (ABCL)

6,605
0,885
( 15,47% )
Mis à jour : 19:23:43

AbCellera Biologics Inc (ABCL) Action

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Statistiques et détails clés

Dernier
6,605
( 15,47% )
Prix Achat
6,60
Prix Vente
6,61
Volume échangé
7 437 976
5,51 Fourchette du Jour 6,695
2,27 Plage de 52 semaines 6,79
Cap du marché
Clôture Veille
5,72
Ouverture
5,52
Dernière Transaction
146
@
6.605
Dernière heure de transaction
19:23:50
Volume financier
US$ 47 322 464
VWAP
6,3623
Volume moyen (3 m)
US$ 4 734 495
Actions en circulation
305 264 947
Rendement du Dividende (LTM)
Ratio Cours sur Bénéfices
-10,93
Bénéfice par action (BPA)
-0,48
Chiffre d'affairess (LTM)
79,21M
Bénéfice net (LTM)
-143,96M

À propos de AbCellera Biologics Inc

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575,... AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a research collaboration and license agreement with Eli Lilly and Company; AbbVie Inc.; and partnership agreement with Viking Global Investors & ArrowMark Partners and Biogen Inc. AbCellera Biologics Inc. was incorporated in 2012 and is headquartered in Vancouver, Canada. Show more

Secteur
Healthcare
Industrie
Biotechnology & Life Sciences
Siège social
Vancouver, Canada
Fondé
2026
AbCellera Biologics Inc est coté dans le secteur Healthcare de la NASDAQ avec le ticker ABCL. Le dernier cours de clôture d'AbCellera Biologics était de US$5,72. Au cours de la dernière année, les actions de AbCellera Biologics ont été négociées dans une fourchette de prix de US$ 2,27 à US$ 6,79.

AbCellera Biologics compte actuellement 305 264 947 actions en circulation. La capitalisation boursière d'AbCellera Biologics est de US$2,02 milliard. AbCellera Biologics a un ratio cours/bénéfice (ratio PE) de -10.93.

Flux d'options AbCellera Biologics (ABCL)

Flux global

Haussier

Prime nette

334k

Calls / Puts

100,00%

Ach. / Vent.

200,00%

OTM / ITM

20,00%

Sweeps Ratio

0,00%

ABCL Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
11.21522.54174397035.396.795.3783306526.07300067CS
41.55530.79207920795.056.793.9492601165.14295955CS
122.98582.45856353593.626.793.2261702784.55427743CS
263.12589.79885057473.486.792.74550460924.17004857CS
524.305187.1739130432.36.792.2754293874.27094428CS
156-0.205-3.010279001476.818.051.890633745514.04373309CS
260-19.085-74.289606850925.6927.46031.890628644726.41811111CS

ABCL - Frequently Asked Questions (FAQ)

What is the current AbCellera Biologics Inc share price?
The current share price of AbCellera Biologics Inc is US$ 6,605
How many AbCellera Biologics Inc shares are in issue?
AbCellera Biologics Inc has 305 264 947 shares in issue
What is the market cap of AbCellera Biologics Inc?
The market capitalisation of AbCellera Biologics Inc is USD 2,02B
What is the 1 year trading range for AbCellera Biologics Inc share price?
AbCellera Biologics Inc has traded in the range of US$ 2,27 to US$ 6,79 during the past year
What is the PE ratio of AbCellera Biologics Inc?
The price to earnings ratio of AbCellera Biologics Inc is -10,93
What is the cash to sales ratio of AbCellera Biologics Inc?
The cash to sales ratio of AbCellera Biologics Inc is 20,23
What is the registered address of AbCellera Biologics Inc?
The registered address for AbCellera Biologics Inc is 150 W 4th Avenue, Vancouver, British Columbia, V5Y 1G6
What is the AbCellera Biologics Inc website address?
The website address for AbCellera Biologics Inc is www.abcellera.com
Which industry sector does AbCellera Biologics Inc operate in?
AbCellera Biologics Inc operates in the Biotechnology & Life Sciences sector

ABCL Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock